Search Results - "LIGORIO, C"

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients by Cappuzzo, F., Jänne, P. A., Skokan, M., Finocchiaro, G., Rossi, E., Ligorio, C., Zucali, P. A., Terracciano, L., Toschi, L., Roncalli, M., Destro, A., Incarbone, M., Alloisio, M., Santoro, A., Varella-Garcia, M.

“…Background: MET amplification has been detected in ∼20% of non-small-cell lung cancer patients (NSCLC) with epidermal growth factor receptor (EGFR) mutations…”
Get full text

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients by Cappuzzo, F., Finocchiaro, G., Rossi, E., Jänne, P.A., Carnaghi, C., Calandri, C., Bencardino, K., Ligorio, C., Ciardiello, F., Pressiani, T., Destro, A., Roncalli, M., Crino, L., Franklin, W. A., Santoro, A., Varella-Garcia, M.

“…Background: Standardized conditions to distinguish subpopulations of colorectal cancer (CRC) patients more and less sensitive to cetuximab therapy remain…”
Get full text

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients by Cappuzzo, F, Varella-Garcia, M, Finocchiaro, G, Skokan, M, Gajapathy, S, Carnaghi, C, Rimassa, L, Rossi, E, Ligorio, C, Di Tommaso, L, Holmes, A J, Toschi, L, Tallini, G, Destro, A, Roncalli, M, Santoro, A, Jänne, P A

“…The impact of KRAS mutations on cetuximab sensitivity in epidermal growth factor receptor fluorescence in situ hybridisation-positive ( EGFR FISH+) metastatic…”
Get full text

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients by Cappuzzo, F., Tallini, G., Finocchiaro, G., Wilson, R.S., Ligorio, C., Giordano, L., Toschi, L., Incarbone, M., Cavina, R., Terracciano, L., Roncalli, M., Alloisio, M., Varella-Garcia, M., Franklin, W.A., Santoro, A.

“…The purpose of this study is to investigate the prognostic role of insulin-like growth factor receptor 1 (IGF1R) expression in surgically resected…”
Get full text

Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non–Small-Cell Lung Cancer by Cappuzzo, Federico, Magrini, Elisabetta, Ceresoli, Giovanni Luca, Bartolini, Stefania, Rossi, Elisa, Ludovini, Vienna, Gregorc, Vanesa, Ligorio, Claudia, Cancellieri, Alessandra, Damiani, Stefania, Spreafico, Anna, Paties, Carlo Terenzio, Lombardo, Laura, Calandri, Cesare, Bellezza, Guido, Tonato, Maurizio, Crinò, Lucio

“…Background: Gefitinib, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has activity against approximately 10% of unselected…”
Get full text

Lymphangiogenesis in Crohn’s disease: an immunohistochemical study using monoclonal antibody D2-40 by Pedica, F., Ligorio, C., Tonelli, P., Bartolini, S., Baccarini, P.

“…Crohn’s disease (CD) is a chronic inflammatory bowel disorder of unknown etiology. An involvement of the intestinal lymphatic system has been suggested…”
Get full text

Four-dimensional imaging and quantification of viscous flow sintering within a 3D printed bioactive glass scaffold using synchrotron X-ray tomography by Nommeots-Nomm, A., Ligorio, C., Bodey, A.J., Cai, B., Jones, J.R., Lee, P.D., Poologasundarampillai, G.

“…Bioglass® was the first material to form a stable chemical bond with human tissue. Since its discovery, a key goal was to produce three-dimensional (3D) porous…”
Get full text

Programmed death ligand 1 (PD-L1) expression status as prognostic factor in early stage non-small cell lung cancer (NSCLC) by D'Arcangelo, M., Puccetti, M., Bravaccini, S., D'Incecco, A., Ligorio, C., Terracciano, L., Damiani, S., Bennati, C., Minuti, G., Vecchiarelli, S., Landi, L., Incarbone, M., Milesi, M., Ravaioli, S., Tumedei, M.M., Rossi, E., Cappuzzo, F.

Get full text

Surrogate predictive biomarkers for response to anti-EGFR agents: state of the art and challenges by Cappuzzo, F, Toschi, L, Finocchiaro, G, Ligorio, C, Santoro, A

“…The epidermal growth factor receptor (EGFR) plays a key role in cancer development and progression in several human malignancies including non-small cell lung…”
Get full text

OC3.03.2 LYMPHONEOGENESIS: A NEW COMPONENT IN INFLAMMATORY BOWEL DISEASE PATHOGENESIS by Correale, C, Vetrano, S, Stefanelli, T, Ligorio, C, Omodei, P, Repici, A, Malesci, A, Dejana, E, Danese, S

Get full text

Surrogate predictive biomarkers for response to anti-EGFR agents: state of the art and challenges by Cappuzzo, F, Toschi, L, Finocchiaro, G, Ligorio, C, Santoro, A

“…The epidermal growth factor receptor (EGFR) plays a key role in cancer development and progression in several human malignancies including non-small cell lung…”
Get full text

Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains by Mishto, Michele, Bellavista, Elena, Santoro, Aurelia, Stolzing, Alexandra, Ligorio, Claudia, Nacmias, Benedetta, Spazzafumo, Liana, Chiappelli, Martina, Licastro, Federico, Sorbi, Sandro, Pession, Annalisa, Ohm, Thomas, Grune, Tilman, Franceschi, Claudio

“…In this study, we investigated the presence and role of immunoproteasome and its LMP2 subunit polymorphism at codon 60 in Alzheimer's disease (AD)…”
Get full text

C-MET gene copy number variation (CNV) analysis by quantitative PCR (qPCR) assay in Caucasian patients with gastric cancer (GC) by Galluccio, N., Ruzzo, A., Canestrari, E., Lorenzini, P., d'Emidio, S., Sisti, V., Catalano, V., Andreoni, F., Zingaretti, C., De Nictolis, M., Ligorio, C., Cappuzzo, F., Magnani, M., Graziano, F.

“…Abstract only…”
Get full text

Insuline like growth factor receptor-1 (IGFR-1), MET, and BRAF and primary resistance to cetuximab therapy in colorectal cancer patients by Finocchiaro, G., Cappuzzo, F., Rossi, E., Toschi, L., Janne, P. A., Roncalli, M., Ligorio, C., Rimassa, L., Santoro, A., Varella-Garcia, M.

“…Abstract only…”
Get full text

EGFR, HER2, and phospho-Akt are not predictive factors for response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) by Toschi, L., Metro, G., Magrini, E., Bartolini, S., Ligorio, C., Finocchiaro, G., Pession, A., Cancellieri, A., Tallini, G., Cappuzzo, F.

“…Abstract only 7111 Background: Response to Epidermal Growth Factor Receptor tyrosine kinase inhibitor (EGFR-TKI) therapy is significantly associated with…”
Get full text

P024 D2-40 IN COLONIC BIOPSIES: A USEFUL TOOL IN THE DIFFERENTIAL DIAGNOSIS BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS by Pedica, F., Ligorio, C., Baccarini, P.

Get full text

High ΔN p63 isoform expression favours recurrences in odontogenic keratocyst—odontogenic keratocystic tumour by Foschini, M.P., Cocchi, R., Marucci, G., Pennesi, M.G., Magrini, E., Ligorio, C., Lombardini, F., Tosi, A.L., Marchetti, C.

Get full text

Surrogate predictive biomarkers for response to anti-EGFR agents : state of the art and challenges: Anti-epidermal growth factor receptor (EGFR) therapy: From science to clinical medicine by CAPPUZZO, F, TOSCHI, L, FINOCCHIARO, G, LIGORIO, C, SANTORO, A

Get full text

Improved efficacy of gefitinib therapy in phospho-Akt positive patients with advanced non-small cell lung cancer by Cappuzzo, F., Magrini, E., Bartolini, S., Ceresoli, G., Ludovini, V., Gregorc, V., Ligorio, C., Lombardo, L., Crinò, L.

“…Abstract only…”
Get full text

Improved efficacy of gefitinib therapy in phospho-Akt positive patients with advanced non-small cell lung cancer by Cappuzzo, F., Magrini, E., Bartolini, S., Ceresoli, G., Ludovini, V., Gregorc, V., Ligorio, C., Lombardo, L., Crinò, L.

“…Abstract only…”
Get full text